Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SEM Stock Forecast 2025-2026
$15.35
Current Price
$1.96B
Market Cap
Buy 5
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to SEM Price Targets
+62.9%
To High Target of $25.00
+36.8%
To Median Target of $21.00
-2.3%
To Low Target of $15.00
SEM Price Momentum
+2.9%
1 Week Change
-6.2%
1 Month Change
-16.1%
1 Year Change
-18.6%
Year-to-Date Change
-30.5%
From 52W High of $22.08
+9.4%
From 52W Low of $14.03
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Select Medical (SEM) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on SEM and similar high-potential opportunities.
Latest SEM Stock Price Targets & Analyst Predictions
Based on our analysis of 13 Wall Street analysts, SEM has a bullish consensus with a median price target of $21.00 (ranging from $15.00 to $25.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $15.35, the median forecast implies a 36.8% upside. This outlook is supported by 5 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Bill Sutherland at Benchmark, projecting a 62.9% upside. Conversely, the most conservative target is provided by Kevin Fischbeck at B of A Securities, suggesting a 2.3% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SEM Analyst Ratings
5
Buy
1
Hold
0
Sell
SEM Price Target Range
Low
$15.00
Average
$21.00
High
$25.00
Current: $15.35
Latest SEM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SEM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 7, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $19.00 |
| Feb 24, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $23.00 |
| Jan 3, 2025 | UBS | A.J. Rice | Neutral | Maintains | $21.00 |
| Nov 25, 2024 | Benchmark | Bill Sutherland | Hold | Downgrade | $0.00 |
| Nov 4, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Nov 4, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $47.00 |
| Nov 1, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Sep 6, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Aug 20, 2024 | B of A Securities | Joanna Gajuk | Buy | Reinstates | $42.00 |
| Aug 5, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Aug 2, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Jul 16, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $48.00 |
| May 6, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $42.00 |
| May 6, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $40.00 |
| May 3, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $39.00 |
| Apr 12, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $39.00 |
| Nov 30, 2023 | UBS | A.J. Rice | Neutral | Initiates | $26.00 |
| Nov 8, 2023 | Benchmark | Bill Sutherland | Buy | Reiterates | $39.00 |
| Aug 7, 2023 | Credit Suisse | Jonathan Yong | Neutral | Maintains | $32.00 |
| Jul 20, 2023 | RBC Capital | Ben Hendrix | Outperform | Reiterates | $38.00 |
Select Medical Holdings Corp. (SEM) Competitors
The following stocks are similar to Select Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Select Medical Holdings Corp. (SEM) Financial Data
Select Medical Holdings Corp. has a market capitalization of $1.96B with a P/E ratio of 24.6x. The company generates $5.22B in trailing twelve-month revenue with a 3.3% profit margin.
Revenue growth is +2.4% quarter-over-quarter, while maintaining an operating margin of +8.3% and return on equity of +7.7%.
Valuation Metrics
Market Cap
$1.96B
Enterprise Value
$5.02B
P/E Ratio
24.6x
PEG Ratio
6.7x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
+2.4%
Gross Margin
+13.3%
Operating Margin
+8.3%
Net Margin
+3.3%
EPS Growth
-41.5%
Financial Health
Cash/Price Ratio
+2.7%
Current Ratio
1.2x
Debt/Equity
136.2x
ROE
+7.7%
ROA
+2.4%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Select Medical Holdings Corp. (SEM) Business Model
About Select Medical Holdings Corp.
What They Do
Provides critical healthcare services in the U.S.
Business Model
The company generates revenue through its extensive network of rehabilitation hospitals, acute care hospitals, outpatient rehabilitation clinics, and occupational health centers. By focusing on high-quality, cost-effective care, it addresses a wide range of patient needs, from recovery-focused services to acute therapies, ensuring a steady stream of service utilization and reimbursement.
Additional Information
Founded in 1996, the company emphasizes patient-centered care and operational excellence, playing a crucial role in the transformation of healthcare services. Its resilience and adaptability in the changing healthcare landscape position it as a significant player in rehabilitation and specialized critical care sectors.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
30,000
CEO
Mr. David S. Chernow
Country
United States
IPO Year
2009
Website
www.selectmedical.comSelect Medical Holdings Corp. (SEM) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Select Medical Lags Q1 Earnings Estimates, Lowers Revenue Outlook
SEM reiterates that earnings for 2025 are likely to be between $1.09 and $1.19 per share.
May 08, 2025
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
SEM expects 2025 earnings to range from $1.09 to $1.19 per share.
Why It Matters
The earnings guidance for 2025 provides clarity on SEM's financial outlook, influencing stock valuation and investor confidence in the company's growth potential.
Source: Zacks Investment Research
Market Sentiment:
Negative
The Best Health Care Stocks to Buy
10 days ago
Quick Summary
Health care stocks can provide a defensive investment option in uncertain markets. Strategies for identifying these stocks are discussed in the full article.
Why It Matters
Health care stocks provide stability during market volatility, making them attractive for risk-averse investors seeking reliable returns and lower correlation with broader market trends.
Source: Kiplinger
Market Sentiment:
Positive
Quick Summary
Select Medical Holdings Corporation (NYSE: SEM) will hold its Q1 2025 earnings call on May 2, 2025, at 9:00 AM ET, featuring executives Robert Ortenzio and Martin Jackson.
Why It Matters
The Q1 2025 earnings call provides insights into Select Medical's financial health and future outlook, influencing investor sentiment and potential investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Select Medical Holdings Corporation (NYSE: SEM) reported its first-quarter results for 2025 and declared a cash dividend on May 1, 2025.
Why It Matters
Select Medical's Q1 results and cash dividend declaration could signal financial health and a commitment to returning value to shareholders, influencing stock performance and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Select Medical (SEM) reported Q3 earnings of $0.44 per share, below the Zacks Consensus Estimate of $0.45, and down from $0.77 per share a year earlier.
Why It Matters
Select Medical's earnings miss signals potential operational challenges and declining profitability, which could negatively impact investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Negative
Select Medical Holdings Corporation to Announce First Quarter 2025 Results on Thursday, May 1, 2025
1 month ago
Quick Summary
Select Medical Holdings Corporation (NYSE: SEM) will report its Q1 2025 financial results on May 1, 2025, after market close.
Why It Matters
Select Medical's upcoming earnings report on May 1, 2025, will provide insights into its financial performance, influencing stock price and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SEM Stock
What is Select Medical Holdings Corp.'s (SEM) stock forecast for 2025?
Based on our analysis of 13 Wall Street analysts, Select Medical Holdings Corp. (SEM) has a median price target of $21.00. The highest price target is $25.00 and the lowest is $15.00.
Is SEM stock a good investment in 2025?
According to current analyst ratings, SEM has 5 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $15.35. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SEM stock?
Wall Street analysts predict SEM stock could reach $21.00 in the next 12 months. This represents a 36.8% increase from the current price of $15.35. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Select Medical Holdings Corp.'s business model?
The company generates revenue through its extensive network of rehabilitation hospitals, acute care hospitals, outpatient rehabilitation clinics, and occupational health centers. By focusing on high-quality, cost-effective care, it addresses a wide range of patient needs, from recovery-focused services to acute therapies, ensuring a steady stream of service utilization and reimbursement.
What is the highest forecasted price for SEM Select Medical Holdings Corp.?
The highest price target for SEM is $25.00 from Bill Sutherland at Benchmark, which represents a 62.9% increase from the current price of $15.35.
What is the lowest forecasted price for SEM Select Medical Holdings Corp.?
The lowest price target for SEM is $15.00 from Kevin Fischbeck at B of A Securities, which represents a -2.3% decrease from the current price of $15.35.
What is the overall SEM consensus from analysts for Select Medical Holdings Corp.?
The overall analyst consensus for SEM is bullish. Out of 13 Wall Street analysts, 5 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $21.00.
How accurate are SEM stock price projections?
Stock price projections, including those for Select Medical Holdings Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 7:00 PM UTC